好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Outcomes in Neurologically Critically Ill Patients with Fixed Dilated Pupils: A Retrospective Cohort Study
Neuro Trauma, Critical Care, and Sports Neurology
P5 - Poster Session 5 (5:30 PM-6:30 PM)
4-053

Identify prognostic markers for patients with unilateral or bilateral fixed, dilated pupils (FDP). 

A fixed, dilated pupil in the setting of neurologic insult typically signifies acute mass effect and herniation. With contemporary neurocritical care, patients with FDP have variable functional outcomes. However, the proportion of patients with good outcomes and patient characteristics associated with good outcomes have not been well described.

From an existing IRB-approved database of 258 neurocritically ill patients who underwent external-ventricular drain (EVD) placement from 2010-2016, all 57 patients who had FDP >4mm were included. Using electronic medical records, demographics data about pre-morbid functional status, admitting diagnoses, radiological characteristics, interventions, and outcomes (discharge Glasgow Coma Scale (GCS) and Glasgow Outcome Scale (GOS)) were collected. Logistic regression was performed to identify factors predictive of mortality and discharge GOS. 

Admission GCS, sulcal effacement on admission or post-FDP imaging, midline shift on post-FDP imaging, maximum pupil size, and bilateral FDP were significantly correlated with patient mortality (p<0.05). Admission GCS and modified fisher, midline shift on post-FDP imaging, and bilateral FDP were significantly correlated with discharge GOS (p<0.05). 

 

Multivariable logistic regression and ordinal logistic regression were performed to ascertain the effect of age, sex, admission GCS, hydrocephalus or midline shift on admission imaging, maximum pupil size, and bilateral FDP on likelihood of patient mortality and discharge GOS, respectively. The multivariable logistic regression model was significant, χ2(8)=28.8, p<.001, and explained 65.0% (Nagelkerke R2) of variance in mortality. Controlling for other variables, high admission GCS was independently predictive of survival to discharge but bilateral FDP and male sex were independently predictive of mortality (p<0.05). Admission GCS (p=0.01) and bilateral FDP (p<0.01) were independently predictive of discharge GOS, controlling for other variables.

Admission GCS and bilateral FDP were independently predictive of mortality and discharge GOS in neurocritically ill patients requiring EVD for CSF diversion.

Authors/Disclosures
Alana Kornspun, MD (University of Pennsylvania)
PRESENTER
No disclosure on file
No disclosure on file
No disclosure on file
Christopher P. Kellner, MD (Mount Sinai Health System) Dr. Kellner has stock in METIS Innovative. Dr. Kellner has stock in Precision Recovery. Dr. Kellner has stock in Synchron. Dr. Kellner has stock in Fluid BioMed. Dr. Kellner has stock in Proprio. Dr. Kellner has stock in Von Vascular. Dr. Kellner has stock in E8. Dr. Kellner has stock in Borvo. Dr. Kellner has stock in Phantom Neuro. Dr. Kellner has stock in Radical. Dr. Kellner has stock in Reach Neuro. Dr. Kellner has stock in Aurenar. The institution of Dr. Kellner has received research support from Integra. The institution of Dr. Kellner has received research support from Penumbra. The institution of Dr. Kellner has received research support from Viz.AI. The institution of Dr. Kellner has received research support from ICE Neurosystems. The institution of Dr. Kellner has received research support from Irras. The institution of Dr. Kellner has received research support from Microtransponder. The institution of Dr. Kellner has received research support from Medtronic. The institution of Dr. Kellner has received research support from Longeviti. The institution of Dr. Kellner has received research support from Endostream. The institution of Dr. Kellner has received research support from CVAID.
Neha Dangayach, MD, FAAN (Icahn School of Medicine At Mount Sinai and Mount Sinai Hospital) Dr. Dangayach has nothing to disclose.